Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$9.7 - $19.65 $969,999 - $1.96 Million
-100,000 Closed
0 $0
Q2 2018

Feb 11, 2021

BUY
$3.88 - $12.74 $384,120 - $1.26 Million
99,000 Added 9900.0%
100,000 $949,000
Q2 2018

Aug 14, 2018

BUY
$3.88 - $12.74 $3,880 - $12,740
1,000 New
1,000 $110,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.18B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.